Article
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA…
International Journal of Chronic Obstructive Pulmonary Disease · 2019 · Singh D, Fabbri LM, Vezzoli S, Petruzzelli S, Papi A
Key facts
| Title | Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA |
|---|---|
| First author | Singh D, Fabbri LM, Vezzoli S, Petruzzelli S, Papi A |
| Journal | International Journal of Chronic Obstructive Pulmonary Disease |
| Published | Feb 28, 2019 |
| DOI | 10.2147/COPD.S196383 |
| Product codes mentioned | KRA, MCW, MCX |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1